These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2575983)

  • 1. Comparative multicentre study of the tolerability and efficacy of epanolol versus nifedipine in patients with stable angina pectoris.
    Readman AS
    Drugs; 1989; 38 Suppl 2():61-5. PubMed ID: 2575983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative multicentre study of the tolerability and efficacy of epanolol versus metoprolol in patients with stable angina pectoris.
    Clark-Turner N
    Drugs; 1989; 38 Suppl 2():55-60. PubMed ID: 2575982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of epanolol and nifedipine in stable angina patients: results of a multicentre trial.
    Blake P; Berry SC; Readman A; Ratcliffe M; Godley M
    Cardiology; 1991; 79(4):249-55. PubMed ID: 1685942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and statistical methodology for the VISA studies.
    Ratcliffe MJ; Godley MJ
    Drugs; 1989; 38 Suppl 2():50-4. PubMed ID: 2575981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of partial agonist activity on the side effects of beta-blockade in patients with chronic stable angina.
    Chambers J; Ong ML; Akhras F; Adam G; Jackson G
    Drugs; 1989; 38 Suppl 2():39-44. PubMed ID: 2575979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epanolol. A new once-daily antianginal agent: dose finding and long term efficacy.
    Akhras F; Jackson G
    Drugs; 1989; 38 Suppl 2():28-34. PubMed ID: 2575977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of clinical trial experience with epanolol.
    Blake P
    Drugs; 1989; 38 Suppl 2():81-5. PubMed ID: 2575988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of epanolol versus metoprolol in angina pectoris: report from a Swedish multicentre study of exercise tolerance.
    Rydén L
    J Intern Med; 1992 Jan; 231(1):7-11. PubMed ID: 1346268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group.
    Boberg J; Larsen FF; Pehrsson SK
    Clin Cardiol; 1992 Aug; 15(8):591-5. PubMed ID: 1354086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epanolol as a model for assessing patient preference in anti-anginal drug therapy.
    Blake P; Lewis JA
    J Clin Pharmacol; 1992 Jan; 32(1):85-90. PubMed ID: 1346791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of epanolol versus metoprolol in angina pectoris. Results from the Swedish Multicenter Study of Exercise Tolerance. The Swedish Multicenter Study Group.
    Rydén L
    Drugs; 1989; 38 Suppl 2():66. PubMed ID: 2575984
    [No Abstract]   [Full Text] [Related]  

  • 12. Dose finding in angina--results with epanolol.
    Omland TM; von Brandis C; Abrahamsen AM
    Drugs; 1989; 38 Suppl 2():35-8. PubMed ID: 2575978
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of epanolol on quality of life.
    Jern S
    Drugs; 1989; 38 Suppl 2():71-4. PubMed ID: 2575987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart disease.
    Wright RA; Perrie AM; Stenhouse F; Alberti KG; Riemersma RA; MacGregor IR; Boon NA
    Eur J Clin Pharmacol; 1994; 46(3):279-82. PubMed ID: 7915237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of carvedilol in comparison with nifedipine sustained-release in chronic stable angina.
    van der Does R; Eberhardt R; Derr I; Ehmer B
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S122-7. PubMed ID: 1378139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of epanolol and metoprolol on the heart measured by 24-hour holter monitoring.
    Withagen AJ; Corbeij HM; Huige MC; Kragten JA; Vermeulen A
    Drugs; 1989; 38 Suppl 2():67-9. PubMed ID: 2575985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of epanolol after acute and chronic oral dosing in elderly patients with stable angina pectoris.
    Hosie J; Scott AK; Petrie JC; Cockshott ID
    Br J Clin Pharmacol; 1990 Mar; 29(3):333-7. PubMed ID: 1968755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of epanolol in elderly patients with stable angina pectoris.
    Marlier R; McAinsh J; Cockshott ID
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):142-4. PubMed ID: 1970734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a single oral administration of Epanolol on exercise tolerance in patients with stable effort angina pectoris.
    Vandenbosch H; Piessens J; De Geest H
    Acta Cardiol; 1991; 46(1):11-25. PubMed ID: 1674394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and tolerability of felodipine and nifedipine in stable angina refractory to beta-blocker therapy].
    Mazzotta G; Falcidieno M; Ravera E; Vecchio C
    G Ital Cardiol; 1996 Apr; 26(4):407-17. PubMed ID: 8707025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.